title: Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment.
abstract: Heart block during sleep has been described in up to 10% of patients with obstructive sleep apnoea. The aim of this study was to determine the relationship between sleep stage, oxygen desaturation and apnoea-associated bradyarrhythmias as well as the effect of nasal continuous positive airway pressure (nCPAP)/nasal bi-level positive airway pressure (nBiPAP) therapy on these arrhythmias in patients without electrophysiological abnormalities. Sixteen patients (14 males and two females, mean age 49.6+/-10.4 yrs) with sleep apnoea and nocturnal heart block underwent polysomnography after exclusion of electrophysiological abnormalities of the sinus node function and atrioventricular (AV) conduction system by invasive electrophysiological evaluation. During sleep, 651 episodes of heart block were recorded, 572 (87.9%) occurred during rapid eye movement (REM) sleep and 79 (12.1%) during nonrapid eye movement (NREM) sleep stages 1 and 2. During REM sleep, the frequency of heart block was significantly higher than during NREM sleep: 0.69+/-0.99 versus 0.02+/-0.04 episodes of heart block x min(-1) of the respective sleep stage (p<0.001). During apnoeas or hypopnoeas, 609 bradyarrhythmias (93.5%) occurred with a desaturation of at least 4%. With nCPAP/ nBiPAP therapy, apnoea/hypopnoea index (AHI) decreased from 75.5+/-39.6 x h(-1) to 3.0+/-6.6 x h(-1) (p<0.01) and the number of arrhythmias from 651 to 72 (p<0.01). We conclude that: 1) 87.9% of apnoea-associated bradyarrhythmias occur during rapid eye movement sleep; 2) the vast majority of heart block episodes occur during a desaturation of at least 4% without a previously described threshold value of 72%; and 3) nasal continuous positive airway pressure or nasal bi-level positive airway pressure is the therapy of choice in patients with apnoea-associated bradyarrhythmias.
authors.affiliation: Dept of Internal Medicine, Schlafmedizinisches Labor, Philipps-University Marburg, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Koehler
authors.forename: E
authors.initials: E
authors.lastname: Fus
authors.forename: W
authors.initials: W
authors.lastname: Grimm
authors.forename: W
authors.initials: W
authors.lastname: Pankow
authors.forename: H
authors.initials: H
authors.lastname: Schäfer
authors.forename: A
authors.initials: A
authors.lastname: Stammnitz
authors.forename: J H
authors.initials: JH
authors.lastname: Peter
mesh_terms: D000328:Adult; D000368:Aged; D001158:Arteries; D001919:Bradycardia / Q000209:etiology / Q000503:physiopathology; D015716:Electrocardiography, Ambulatory; D004594:Electrophysiology; D006327:Heart Block / Q000209:etiology*; D006801:Humans; D008875:Middle Aged; D009296:Nasal Cavity / Q000503:physiopathology; D010100:Oxygen / Q000097:blood; D017286:Polysomnography; D011175:Positive-Pressure Respiration; D012891:Sleep Apnea Syndromes / Q000150:complications* / Q000628:therapy*; D012894:Sleep Stages / Q000502:physiology; D012895:Sleep, REM / Q000502:physiology
chemical_list: D010100:Oxygen